Search
for
Sort by
Research 31–60 of 1000+
- 4-aminopyridine promotes accelerated skin wound healing via neurogenic-mediator expression
- New effects of caffeine on corticotropin‐releasing hormone (CRH)‐induced stress along the intrafollicular classical hypothalamic–pituitary–adrenal (HPA) axis (CRH‐R1/2, IP<sub>3</sub>‐R, ACTH, MC‐R2) and the neurogenic non‐HPA axis (substance P, p75<sup>NTR</sup>and TrkA) in<i>ex vivo</i>human male androgenetic scalp hair follicles
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- Ayurveda-based Botanicals as Therapeutic Adjuvants in Paclitaxel-induced Myelosuppression
- Primary cutaneous diffuse large B‑cell lymphoma of the scalp: A case report and brief review of the literature
- Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq”
- Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer
- Pegylated Liposomal Doxorubicin in the Treatment of Breast Cancer
- Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children
- Albendazole treatment of echinococcosis in humans: Effects on microsomal metabolism and drug tolerance
- Mitoxantrone
- Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: first observations from an interdisciplinary breast cancer centre in Germany
- First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
- Principles of chemotherapy
- Chemotherapy-induced toxicity—a secondary effect caused by released DNA?
- Induction plus adjuvant chemotherapy, combined treatment with nimotuzumab, and intensity-modulated radiation therapy for N3 stage nasopharyngeal carcinoma
- Severe adverse reaction induced by albendazole and praziquantel for cystic echinococcosis
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Life threatening macrophage activation syndrome as the initial presentation of systemic lupus erythematosus: A case report and review of the literature
- Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events
- Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross-sectional survey in China
- Drug utilization pattern and adverse drug reactions of chemotherapy in pediatric patients at Muhimbili National Hospital, Tanzania
- Retiform Purpura Caused by the Use of Cocaine, That Was Probably Adulterated with Levamisole
- Pseudoglucagonoma Syndrome Following Frey’s Surgery: A Case Report of a Rare Presentation
- Referee report. For: Drug utilization pattern and adverse drug reactions of chemotherapy in pediatric patients at Muhimbili National Hospital, Tanzania [version 1; peer review: 1 approved, 1 approved with reservations]
- BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience
- Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients
- Complications associated with oncological therapy - how to minimize?